These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22817719)

  • 1. Towards understanding the phosphorylation code of tau.
    Lippens G; Amniai L; Wieruszeski JM; Sillen A; Leroy A; Landrieu I
    Biochem Soc Trans; 2012 Aug; 40(4):698-703. PubMed ID: 22817719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease.
    Landrieu I; Leroy A; Smet-Nocca C; Huvent I; Amniai L; Hamdane M; Sibille N; Buée L; Wieruszeski JM; Lippens G
    Biochem Soc Trans; 2010 Aug; 38(4):1006-11. PubMed ID: 20658994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK3: a possible link between beta amyloid peptide and tau protein.
    Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
    Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.
    Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM
    Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules.
    Amniai L; Barbier P; Sillen A; Wieruszeski JM; Peyrot V; Lippens G; Landrieu I
    FASEB J; 2009 Apr; 23(4):1146-52. PubMed ID: 19074508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J
    FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR analysis of a Tau phosphorylation pattern.
    Landrieu I; Lacosse L; Leroy A; Wieruszeski JM; Trivelli X; Sillen A; Sibille N; Schwalbe H; Saxena K; Langer T; Lippens G
    J Am Chem Soc; 2006 Mar; 128(11):3575-83. PubMed ID: 16536530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.
    Fischer D; Mukrasch MD; Biernat J; Bibow S; Blackledge M; Griesinger C; Mandelkow E; Zweckstetter M
    Biochemistry; 2009 Oct; 48(42):10047-55. PubMed ID: 19769346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease.
    Preuss U; Mandelkow EM
    Eur J Cell Biol; 1998 Jul; 76(3):176-84. PubMed ID: 9716264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STOX1A induces phosphorylation of tau proteins at epitopes hyperphosphorylated in Alzheimer's disease.
    van Abel D; Abdulhamid O; Scheper W; van Dijk M; Oudejans CB
    Neurosci Lett; 2012 Oct; 528(2):104-9. PubMed ID: 22995177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probable participation of 14-3-3 in tau protein oligomerization and aggregation.
    Sluchanko NN; Gusev NB
    J Alzheimers Dis; 2011; 27(3):467-76. PubMed ID: 21876254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain protein kinase PK40erk converts TAU into a PHF-like form as found in Alzheimer's disease.
    Roder HM; Eden PA; Ingram VM
    Biochem Biophys Res Commun; 1993 Jun; 193(2):639-47. PubMed ID: 8512563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of microtubule promoting and binding activity of tau with its phosphorylation sites].
    Wang J; Wei Z; Wang Q; Grundke-Iqbal I; Iqbal K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Apr; 22(2):120-3. PubMed ID: 12903511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons.
    Lu Q; Soria JP; Wood JG
    J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phosphorylation of tau and Alzheimer's disease].
    García T; Jay D
    Gac Med Mex; 2004; 140(3):329-33. PubMed ID: 15259345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational modifications of tau protein: implications for Alzheimer's disease.
    Martin L; Latypova X; Terro F
    Neurochem Int; 2011 Mar; 58(4):458-71. PubMed ID: 21215781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer's disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer's disease?
    Schnurra I; Bernstein HG; Riederer P; Braunewell KH
    Neurobiol Dis; 2001 Oct; 8(5):900-9. PubMed ID: 11592857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.